Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Epigenetics and breast cancers.

Vo AT, Millis RM.

Obstet Gynecol Int. 2012;2012:602720. doi: 10.1155/2012/602720. Epub 2012 Apr 10.

2.

Regulation of estrogen receptor α by histone methyltransferase SMYD2-mediated protein methylation.

Zhang X, Tanaka K, Yan J, Li J, Peng D, Jiang Y, Yang Z, Barton MC, Wen H, Shi X.

Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17284-9. doi: 10.1073/pnas.1307959110. Epub 2013 Oct 7.

3.

Methylation of the ER-alpha Promoter Is Influenced by its Ligand Estrogen in Osteosarcoma Cells SAOS-2 In Vitro.

Tübel J, Kuntz L, Marthen C, Schmitt A, Wiest I, VON Eisenhart-Rothe R, Jeschke U, Burgkart R.

Anticancer Res. 2016 Jun;36(6):3199-204.

PMID:
27272849
4.

Role of hMOF-dependent histone H4 lysine 16 acetylation in the maintenance of TMS1/ASC gene activity.

Kapoor-Vazirani P, Kagey JD, Powell DR, Vertino PM.

Cancer Res. 2008 Aug 15;68(16):6810-21. doi: 10.1158/0008-5472.CAN-08-0141.

5.

Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure.

Woodfield GW, Hitchler MJ, Chen Y, Domann FE, Weigel RJ.

Clin Cancer Res. 2009 Jun 1;15(11):3672-9. doi: 10.1158/1078-0432.CCR-08-2343. Epub 2009 May 19.

6.

Histone lysine trimethylation or acetylation can be modulated by phytoestrogen, estrogen or anti-HDAC in breast cancer cell lines.

Dagdemir A, Durif J, Ngollo M, Bignon YJ, Bernard-Gallon D.

Epigenomics. 2013 Feb;5(1):51-63. doi: 10.2217/epi.12.74.

PMID:
23414320
7.

Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters.

Kininis M, Chen BS, Diehl AG, Isaacs GD, Zhang T, Siepel AC, Clark AG, Kraus WL.

Mol Cell Biol. 2007 Jul;27(14):5090-104. Epub 2007 May 21.

8.

Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells.

Sharma D, Blum J, Yang X, Beaulieu N, Macleod AR, Davidson NE.

Mol Endocrinol. 2005 Jul;19(7):1740-51. Epub 2005 Mar 3.

PMID:
15746193
9.

A role for methyl-CpG binding domain protein 2 in the modulation of the estrogen response of pS2/TFF1 gene.

Chatagnon A, Ballestar E, Esteller M, Dante R.

PLoS One. 2010 Mar 12;5(3):e9665. doi: 10.1371/journal.pone.0009665.

10.

Epigenetic landscape of amphetamine and methamphetamine addiction in rodents.

Godino A, Jayanthi S, Cadet JL.

Epigenetics. 2015;10(7):574-80. doi: 10.1080/15592294.2015.1055441. Review.

11.

Hematopoietic-specific activators establish an overlapping pattern of histone acetylation and methylation within a mammalian chromatin domain.

Kiekhaefer CM, Grass JA, Johnson KD, Boyer ME, Bresnick EH.

Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14309-14. Epub 2002 Oct 11.

14.

Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis.

Shi L, Sun L, Li Q, Liang J, Yu W, Yi X, Yang X, Li Y, Han X, Zhang Y, Xuan C, Yao Z, Shang Y.

Proc Natl Acad Sci U S A. 2011 May 3;108(18):7541-6. doi: 10.1073/pnas.1017374108. Epub 2011 Apr 18.

15.

Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation.

Kondo Y, Shen L, Cheng AS, Ahmed S, Boumber Y, Charo C, Yamochi T, Urano T, Furukawa K, Kwabi-Addo B, Gold DL, Sekido Y, Huang TH, Issa JP.

Nat Genet. 2008 Jun;40(6):741-50. doi: 10.1038/ng.159. Epub 2008 May 18.

PMID:
18488029
16.

Gene methylation in gastric cancer.

Qu Y, Dang S, Hou P.

Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10. Review.

17.

Histone H3K4 trimethylation: dynamic interplay with pre-mRNA splicing.

Davie JR, Xu W, Delcuve GP.

Biochem Cell Biol. 2016 Feb;94(1):1-11. doi: 10.1139/bcb-2015-0065. Epub 2015 Jul 15. Review.

PMID:
26352678
20.

Histone-modifier gene expression profiles are associated with pathological and clinical outcomes in human breast cancer.

Patani N, Jiang WG, Newbold RF, Mokbel K.

Anticancer Res. 2011 Dec;31(12):4115-25.

PMID:
22199269

Supplemental Content

Support Center